Jacobio Pharmaceuticals Group Co Ltd
Jacobio Pharmaceuticals Group's GHG Emissions Data Preview
In 2023, Jacobio Pharmaceuticals Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Jacobio Pharmaceuticals Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Jacobio Pharmaceuticals Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Jacobio Pharmaceuticals Group amounted to 1,510.42 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Jacobio Pharmaceuticals Group increased by 68.77%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Jacobio Pharmaceuticals Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Jacobio Pharmaceuticals Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Jacobio Pharmaceuticals Group were 33.98 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Jacobio Pharmaceuticals Group reduced its Scope 1 emissions over time?
Since 2021, Jacobio Pharmaceuticals Group's Scope 1 emissions have increased by 205.85%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Jacobio Pharmaceuticals Group's Scope 1 emissions increased by 239.8%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Jacobio Pharmaceuticals Group's Scope 2 emissions?
In 2023, Jacobio Pharmaceuticals Group reported Scope 2 greenhouse gas (GHG) emissions of 1,476.44 tCOâ‚‚e without specifying the calculation method.
Has Jacobio Pharmaceuticals Group reduced its Scope 2 emissions over time?
Since 2021, Jacobio Pharmaceuticals Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 80.2%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Jacobio Pharmaceuticals Group's Scope 2 emissions (Unspecified Calculation Method) rose by 66.83% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Jacobio Pharmaceuticals Group use for Scope 2 reporting?
In 2023, Jacobio Pharmaceuticals Group reported its Scope 2 emissions using an unspecified methodology.
Jacobio Pharmaceuticals Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)